[Lung infiltrations in Hodgkin lymphoma].
We report the case of a young patient presenting with cervical lymphadenopathy and interstitial pulmonary infiltrates due to Hodgkin's Disease. Although lung involvement regressed under chemotherapy, we observed new alveolar infiltrates during treatment. Steroid administration after exclusion of an infectious cause was followed by rapid clinical and radiological improvement, indicating the probable presence of pulmonary bleomycine toxicity.
Ciurea-Löchel
A
A
Medizinische Poliklinik, Universitätsspital Zürich. annette.ciurea@spitalbuelach.ch
Ciurea
A
A
Stey
C
C
Pestalozzi
B
B
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D014057:Tomography, X-Ray Computed
D001761:Bleomycin; D011241:Prednisone
Lungeninfiltrate bei Hodgkin Lymphom.